• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与α-1 抗胰蛋白酶缺乏症相关的等位基因和基因型在临床和一般人群中的频率:关于漏诊的启示。

Frequency of alleles and genotypes associated with alpha-1 antitrypsin deficiency in clinical and general populations: Revelations about underdiagnosis.

机构信息

Servicio de Neumología del Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Canary Islands, Spain.

Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna, Área de Genética. La Laguna, Tenerife, Spain.

出版信息

Pulmonology. 2023 May-Jun;29(3):214-220. doi: 10.1016/j.pulmoe.2022.01.017. Epub 2022 Mar 26.

DOI:10.1016/j.pulmoe.2022.01.017
PMID:35346640
Abstract

BACKGROUND AND OBJECTIVE

Alpha-1 antitrypsin deficiency (AATD) is an underdiagnosed hereditary condition that promotes the development of lung and liver diseases, and the most common potentially life-threatening genetic condition in Caucasian adults. In this study, the clinical and genetic profile of pulmonary patients from a single center in La Palma Island (Canary Islands, Spain) was assessed to predict how to increase AATD diagnosis.

METHODS

AATD was tested in 1,493 pulmonary outpatients without regard to respiratory symptoms and 465 newborns. Variants of the SERPINA1 gene were characterised by real-time PCR, DNA sequencing, molecular haplotyping and phenotyping (AAT isoelectric focusing). Different respiratory pathologies were diagnosed in patients and their levels of serum AAT were measured by nephelometry.

RESULTS

The prevalence of pneumological patients with AATD alleles was 30.5%, including PIS, PIZ and 6 rare genetic variants. Certain deficiency genotypes were unevenly distributed among patients diagnosed with respiratory diseases: PIZZ (71.4%) and PISS (34.8%) genotypes were more represented in patients with chronic obstructive pulmonary disease (COPD), whereas PIMZ (27.7%) and PISZ (34.5%) genotypes were more abundant in patients with bronchial asthma. The estimated frequency of PIS and PIZ alleles in the general population was 8.2% and 2.1%, respectively. A very significant enrichment (p< 0.01) of PIS allele, independent of the PIZ allele, was detected in the clinical population.

CONCLUSIONS

AATD diagnosis would improve if both the COPD and the asthmatic patients were included to screening programs. The prevalence of PI*ZZ genotype in La Palma (1/2,162) was relatively high within Spain (average 1/3,344).

摘要

背景与目的

α-1 抗胰蛋白酶缺乏症(AATD)是一种未被充分诊断的遗传性疾病,可导致肺部和肝脏疾病的发生,是白种成年人中最常见的潜在危及生命的遗传疾病。在这项研究中,评估了来自西班牙拉帕尔马岛(加那利群岛)单一中心的肺部患者的临床和遗传特征,以预测如何增加 AATD 的诊断率。

方法

在 1493 名无呼吸系统症状的肺科门诊患者和 465 名新生儿中检测了 AATD。通过实时 PCR、DNA 测序、分子单体型分析和表型(AAT 等电聚焦)对 SERPINA1 基因的变异进行了特征分析。对患者进行了不同的呼吸病理学诊断,并通过散射比浊法测量了其血清 AAT 水平。

结果

携带 AATD 等位基因的肺科患者患病率为 30.5%,包括 PIS、PIZ 和 6 种罕见的遗传变异。某些缺陷基因型在诊断为呼吸系统疾病的患者中分布不均:PIZZ(71.4%)和 PISS(34.8%)基因型在慢性阻塞性肺疾病(COPD)患者中更为常见,而 PIMZ(27.7%)和 PISZ(34.5%)基因型在支气管哮喘患者中更为丰富。PIS 和 PIZ 等位基因在普通人群中的估计频率分别为 8.2%和 2.1%。在临床人群中,PIS 等位基因的丰度显著增加(p<0.01),与 PIZ 等位基因无关。

结论

如果将 COPD 和哮喘患者都纳入筛查计划,AATD 的诊断率将会提高。在拉帕尔马(1/2162),PI*ZZ 基因型的流行率相对较高(西班牙平均为 1/3344)。

相似文献

1
Frequency of alleles and genotypes associated with alpha-1 antitrypsin deficiency in clinical and general populations: Revelations about underdiagnosis.与α-1 抗胰蛋白酶缺乏症相关的等位基因和基因型在临床和一般人群中的频率:关于漏诊的启示。
Pulmonology. 2023 May-Jun;29(3):214-220. doi: 10.1016/j.pulmoe.2022.01.017. Epub 2022 Mar 26.
2
The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis.α-1 抗胰蛋白酶基因型在 COPD/肺气肿、哮喘和支气管扩张症患者中的分布。
Int J Chron Obstruct Pulmon Dis. 2020 Nov 6;15:2827-2836. doi: 10.2147/COPD.S271810. eCollection 2020.
3
An Alpha-1 Antitrypsin Deficiency Screening Study in Patients with Chronic Obstructive Pulmonary Disease, Bronchiectasis, or Asthma in Turkey.土耳其慢性阻塞性肺疾病、支气管扩张或哮喘患者的α-1 抗胰蛋白酶缺乏症筛查研究。
Int J Chron Obstruct Pulmon Dis. 2023 Nov 28;18:2785-2794. doi: 10.2147/COPD.S425835. eCollection 2023.
4
The prevalence of PI*S and PI*Z SERPINA1 alleles in healthy individuals and COPD patients in Saudi Arabia: A case-control study.沙特阿拉伯健康个体和慢性阻塞性肺疾病(COPD)患者中PI*S和PI*Z SERPINA1等位基因的患病率:一项病例对照研究。
Medicine (Baltimore). 2017 Oct;96(42):e8320. doi: 10.1097/MD.0000000000008320.
5
Prevalence of alpha-1 antitrypsin deficiency and allele frequency in patients with COPD in Brazil.巴西慢性阻塞性肺疾病患者中α-1抗胰蛋白酶缺乏症的患病率及等位基因频率
J Bras Pneumol. 2016 Sep-Oct;42(5):311-316. doi: 10.1590/S1806-37562015000000180.
6
Is an integrative laboratory algorithm more effective in detecting alpha-1-antitrypsin deficiency in patients with premature chronic obstructive pulmonary disease than AAT concentration based screening approach?与基于α1抗胰蛋白酶(AAT)浓度的筛查方法相比,综合实验室算法在检测慢性阻塞性肺疾病(COPD)患者α1抗胰蛋白酶缺乏症方面是否更有效?
Biochem Med (Zagreb). 2014;24(2):293-8. doi: 10.11613/BM.2014.032. Epub 2014 Jun 15.
7
Identification of a new defective SERPINA1 allele (PI*Z) encoding an alpha-1-antitrypsin with altered glycosylation pattern.鉴定一种新的缺陷型 SERPINA1 等位基因(PI*Z),其编码的 α-1-抗胰蛋白酶具有改变的糖基化模式。
Respir Med. 2017 Oct;131:114-117. doi: 10.1016/j.rmed.2017.08.015. Epub 2017 Aug 16.
8
Prevalence of Alpha-1 Antitrypsin Deficiency Alleles in a Lithuanian Cohort of Wheezing Small Children.喘息性细支气管炎患儿的α-1 抗胰蛋白酶缺乏等位基因在立陶宛队列中的流行率。
Adv Respir Med. 2024 Aug 5;92(4):291-299. doi: 10.3390/arm92040028.
9
Alpha-1 Antitrypsin Deficiency in COPD Patients: A Cross-Sectional Study.慢性阻塞性肺疾病患者的α-1 抗胰蛋白酶缺乏症:一项横断面研究。
Arch Bronconeumol. 2015 Nov;51(11):539-43. doi: 10.1016/j.arbres.2015.01.008. Epub 2015 Mar 21.
10
Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.α-1抗胰蛋白酶缺乏症慢性阻塞性肺疾病患者的主动病例筛查及静脉注射α-1抗胰蛋白酶治疗的指征:最新进展
Arch Bronconeumol. 2015 Apr;51(4):185-92. doi: 10.1016/j.arbres.2014.05.008. Epub 2014 Jul 12.

引用本文的文献

1
Alpha-1 Antitrypsin Deficiency and Bronchial Asthma: Current Challenges.α-1抗胰蛋白酶缺乏症与支气管哮喘:当前挑战
Biomolecules. 2025 Jun 3;15(6):807. doi: 10.3390/biom15060807.
2
and Alleles of Gene Are Associated With Specific Variants of a BRD4-Independent Enhancer.并且该基因的等位基因与一种不依赖BRD4的增强子的特定变体相关。
Hum Mutat. 2024 Jun 25;2024:6472805. doi: 10.1155/2024/6472805. eCollection 2024.
3
Can Quality of Life Tests Be Useful in Patients Affected by Alpha-1 Antitrypsin Deficiency?生活质量测试对α-1抗胰蛋白酶缺乏症患者有用吗?
J Clin Med. 2024 Dec 17;13(24):7711. doi: 10.3390/jcm13247711.
4
Prevalence of Alpha-1 Antitrypsin Deficiency Alleles in a Lithuanian Cohort of Wheezing Small Children.喘息性细支气管炎患儿的α-1 抗胰蛋白酶缺乏等位基因在立陶宛队列中的流行率。
Adv Respir Med. 2024 Aug 5;92(4):291-299. doi: 10.3390/arm92040028.
5
Maternal serum alpha-1 antitrypsin levels in spontaneous preterm and term pregnancies.自发性早产和足月产孕妇血清α1-抗胰蛋白酶水平。
Sci Rep. 2024 May 11;14(1):10819. doi: 10.1038/s41598-024-61206-z.
6
Testing Alpha-1 Antitrypsin Deficiency in Black Populations.检测黑人群体中的α-1 抗胰蛋白酶缺乏症。
Adv Respir Med. 2023 Dec 19;92(1):1-12. doi: 10.3390/arm92010001.
7
[Detection of cases of Alpha-1 Antitrypsin Deficiency, Should We Restrict or Expand?].[α-1抗胰蛋白酶缺乏症病例的检测,我们应该限制还是扩大?]
Open Respir Arch. 2023 Aug 7;5(3):100262. doi: 10.1016/j.opresp.2023.100262. eCollection 2023 Jul-Sep.
8
Normal Alpha-1-Antitrypsin Variants Display in Serum Allele-Specific Protein Levels.正常的 Alpha-1-抗胰蛋白酶变异体在血清中显示出等位基因特异性蛋白水平。
J Proteome Res. 2023 Apr 7;22(4):1331-1338. doi: 10.1021/acs.jproteome.2c00833. Epub 2023 Mar 22.
9
Pulmonary Function and Respiratory Diseases in Different Genotypes of Alpha-1 Antitrypsin Deficiency.α-1抗胰蛋白酶缺乏症不同基因型中的肺功能与呼吸系统疾病
Turk Thorac J. 2022 Nov;23(6):376-382. doi: 10.5152/TurkThoracJ.2022.22001.
10
Is the determination of C-reactive protein really necessary in the diagnosis of Alpha-1 antitrypsin deficiency?在α-1抗胰蛋白酶缺乏症的诊断中,真的有必要测定C反应蛋白吗?
Clin Respir J. 2022 May;16(5):420-422. doi: 10.1111/crj.13494. Epub 2022 May 17.